Coronavirus OL infection may therefore impact the demyelination process in those with MS by increasing the CD8+ T cell inflammatory response, as well as delaying or inhibiting remyelination potential by affecting OPCs (83). This evidence concerns the gene CD8A and myeloid sarcoma.